Dung‐Fang Lee

The University of Texas MD Anderson Cancer Center — United States

Medicine · Health Sciences

47h-index11.1kcitations237works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer-related Molecular Pathways(77), RNA modifications and cancer(46), Pluripotent Stem Cells Research(37), CRISPR and Genetic Engineering(30), interferon and immune responses(18)

Publications237 total

Supplementary Data 2 from Li–Fraumeni Syndrome–Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death
2025Open Access
Supplementary Figures from Li–Fraumeni Syndrome–Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death
2025Open Access
Supplementary Table 1 from Li–Fraumeni Syndrome–Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death
2025Open Access
Supplementary Data 3 from Li–Fraumeni Syndrome–Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death
2025Open Access
Supplementary Data 5 from Li–Fraumeni Syndrome–Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death
2025Open Access
Supplementary Data 1 from Li–Fraumeni Syndrome–Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death
2025Open Access
Supplementary Data 4 from Li–Fraumeni Syndrome–Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death
2025Open Access
Supplementary Table 2 from Li–Fraumeni Syndrome–Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death
2025Open Access
Supplementary Data 6 from Li–Fraumeni Syndrome–Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death
2025Open Access
Supplementary Table 1 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants
2025Open Access
Supplementary Table 5 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants
2025Open Access
Supplementary Figures from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants
2025Open Access
Supplementary Table 2 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants
2025Open Access
Supplementary Table 4 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants
2025Open Access
Supplementary Table 3 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants
2025Open Access
Investigating prognostic features in high-grade serous ovarian cancer through gene regulatory network inference with single-cell transcriptomic profiles
Scientific Reports·2025Open Access
Generation of Region-specific Airway Basal Stem Cells from Human Pluripotent Stem Cells via Regulation of BMP-NOGGIN Axis
2025Open Access
A <i>TP53</i> Intron-Derived Peptide Promotes Tumor Survival
2025Open Access
Large-scale CRISPR screening in primary human 3D gastric organoids enables comprehensive dissection of gene-drug interactions
Nature Communications·2025· 4 citedOpen Access
Human iPSC-based breast cancer model identifies S100P-dependent cancer stemness induced by <i>BRCA1</i> mutation
Science Advances·2025· 1 citedOpen Access
page 1 of 12Next →

Frequent Co-authors

Mien‐Chie Hung(24), Weiya Xia(16), Ihor R. Lemischka(16), Long‐Yuan Li(11), Christoph Schaniel(9), Jie Su(9), Qingqing Ding(9), Jung-Mao Hsu(9), Chien‐Chen Lai(8), Hsu-Ping Kuo(8), Julian A. Gingold(8), Jer-Yen Yang(7), Chun‐Te Chen(7), Chao‐Kai Chou(6), Ruiying Zhao(6), Longfei Huo(6), Ana Sevilla(5), Betty Chang(5), Yongkun Wei(5), Fuu‐Jen Tsai(5)